RI Mobile platform provide clinicians with the untethered surveillance of patient condition. Credit: Olga Kononenko on Unsplash.

PeraHealth customer Yale New Haven Health (YNHH) has launched Rothman Index Mobile (RI Mobile) for untethered surveillance of patient condition.

RI Mobile platform enables clinicians to access the Rothman Index from their mobile devices. It untethers clinicians from the EMR computer screen and provides remote access to patient surveillance tools that analyse patient trends and alerts.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The device is claimed to help on-the-go clinicians to detect at-risk patients  quickly. Furthermore, it actively sends patient deterioration alerts to clinicians.

Yale New Haven Health has collaborated with PeraHealth for testing and validating new applications of the Rothman Index.

The early implementation of RI Mobile technology is claimed to have provided YNHH greater clinical efficiency by reducing time to respond to patient deterioration.

The Rothman Index is claimed to be the only proven algorithm that derives one simple score from the vast amount of data in the electronic medical record to generate a picture of any patient’s condition over time – despite age, and disease.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It can also detect patient deterioration well in adavance than existing scores and systems, the company stated.

PeraHealth co-founder and CEO Michael Rothman said: “Yale New Haven Health has been a strategic partner and advocate of our technology for many years.”

“We are very pleased to see our RI Mobile technology in the hands of clinicians, allowing them to access critical patient condition information from anywhere in the hospital.”

PeraHealth cited that use of the Rothman Index by YNHH brought positive outcomes including 26% year-over-year mortality reduction, 44% decrease in hospital-acquired sepsis cases, 29% mortality reduction in patients assigned a sepsis DRG.